ICD-10: M02.35

Reiter's disease, also known as reactive arthritis, is a type of inflammatory arthritis that typically occurs following an infection, particularly in the urogenital or gastrointestinal tract. The ICD-10 code M02.35 specifically refers to Reiter's disease affecting the hip. Understanding the clinical presentation, signs, symptoms, and patient characteristics associated with this condition is crucial for accurate diagnosis and management.

Clinical Presentation

Overview

Reiter's disease is characterized by a triad of symptoms: arthritis, urethritis, and conjunctivitis. However, not all patients will present with all three symptoms. The condition often develops after a triggering infection, which can lead to joint inflammation, particularly in the lower extremities, including the hips.

Signs and Symptoms

1. Joint Pain and Swelling:
   - Patients typically experience pain and swelling in the affected hip joint. This pain may be acute and can limit mobility.
   - The pain is often described as deep and may worsen with activity or weight-bearing.

2. Stiffness:
   - Morning stiffness is common, which may improve with movement throughout the day. This stiffness can be particularly pronounced after periods of inactivity.

3. Systemic Symptoms:
   - Patients may also report systemic symptoms such as fever, fatigue, and malaise, which can accompany the inflammatory process.

4. Skin Manifestations:
   - Some individuals may develop skin lesions, such as keratoderma blennorrhagicum, which are typically associated with reactive arthritis.

5. Urethritis and Conjunctivitis:
   - Although not always present, urethritis (inflammation of the urethra) and conjunctivitis (inflammation of the eye) can occur, particularly in the context of a preceding infection.

Patient Characteristics

1. Demographics:
   - Reiter's disease is more common in young adults, particularly males aged 20 to 40 years. However, it can affect individuals of any age and gender.

2. Pre-existing Conditions:
   - Patients with a history of sexually transmitted infections (STIs) or gastrointestinal infections (such as those caused by Chlamydia, Salmonella, or Shigella) are at higher risk for developing Reiter's disease.

3. Genetic Factors:
   - There is a notable association with the HLA-B27 antigen, which is present in a significant proportion of patients with reactive arthritis. This genetic predisposition may influence the severity and course of the disease.

4. Lifestyle Factors:
   - Certain lifestyle factors, such as smoking and a sedentary lifestyle, may exacerbate symptoms or increase the risk of developing the condition.

Conclusion

Reiter's disease affecting the hip (ICD-10 code M02.35) presents with a combination of joint pain, swelling, and systemic symptoms, often following an infection. Understanding the clinical signs and patient characteristics is essential for healthcare providers to make an accurate diagnosis and develop an effective treatment plan. Early recognition and management can help mitigate the impact of this condition on a patient's quality of life.

Reiter's disease, classified under ICD-10 code M02.35, is a form of reactive arthritis that can affect the hip joint among others. This condition is characterized by inflammation that typically follows an infection, often in the urogenital or gastrointestinal tract. Below are alternative names and related terms associated with Reiter's disease, particularly in the context of its classification and understanding.

Alternative Names for Reiter's Disease

1. Reactive Arthritis: This is the most common alternative name for Reiter's disease, as it is often triggered by an infection elsewhere in the body, leading to joint inflammation.

2. Post-Infectious Arthritis: This term emphasizes the condition's association with preceding infections, particularly those affecting the urogenital or gastrointestinal systems.

3. Urethritis-Associated Arthritis: This name highlights the connection between urethritis (inflammation of the urethra) and the development of arthritis, which is a hallmark of Reiter's disease.

4. Syndrome of Reiter: This term is sometimes used to describe the combination of symptoms associated with the disease, including arthritis, urethritis, and conjunctivitis.

5. Reiter's Syndrome: While often used interchangeably with Reiter's disease, this term can also refer to the broader set of symptoms that may accompany the condition.

Related Terms

1. M02.3: This is the broader ICD-10 code category for Reiter's disease, which includes various manifestations of the condition.

2. M02.351: This specific code refers to Reiter's disease affecting the right hip, indicating the need for precise coding in medical documentation.

3. M02.352: This code denotes Reiter's disease affecting the left hip, further specifying the location of the condition.

4. Arthritis: A general term that encompasses various types of joint inflammation, including those seen in Reiter's disease.

5. Spondyloarthritis: A group of inflammatory rheumatic diseases that includes reactive arthritis, highlighting the overlap in symptoms and pathophysiology.

6. HLA-B27 Positive: Many patients with Reiter's disease test positive for this genetic marker, which is associated with a higher risk of developing certain autoimmune conditions, including reactive arthritis.

Conclusion

Understanding the alternative names and related terms for ICD-10 code M02.35 is crucial for accurate diagnosis, treatment, and documentation in medical settings. The terminology reflects the condition's infectious origins and its classification within the broader spectrum of arthritic diseases. This knowledge aids healthcare professionals in communicating effectively about the condition and ensuring appropriate care for affected patients.

Reiter's disease, also known as reactive arthritis, is a type of inflammatory arthritis that can occur following an infection, particularly in the urogenital or gastrointestinal tract. The ICD-10 code M02.35 specifically refers to Reiter's disease affecting the hip. The diagnosis of Reiter's disease involves several criteria, which can be categorized into clinical, laboratory, and imaging findings.

Clinical Criteria

1. History of Infection: A recent history of a genitourinary or gastrointestinal infection is often noted. Common pathogens include Chlamydia trachomatis, Salmonella, Shigella, and Campylobacter.

2. Arthritis Symptoms: Patients typically present with:
   - Joint pain and swelling, particularly in the lower extremities.
   - Asymmetrical involvement of joints, often affecting the knees, ankles, and feet, but in this case, specifically the hip.

3. Extra-Articular Manifestations: These may include:
   - Urethritis or cervicitis.
   - Conjunctivitis or uveitis.
   - Skin lesions, such as keratoderma blennorrhagicum or circinate balanitis.

Laboratory Criteria

1. Serological Tests: While there is no specific test for Reiter's disease, the following may be performed:
   - HLA-B27 Antigen: A significant percentage of patients with Reiter's disease are positive for this antigen, although it is not definitive for diagnosis.
   - Infection Testing: Tests to identify previous infections, such as PCR or cultures for Chlamydia or other pathogens.

2. Inflammatory Markers: Blood tests may show elevated inflammatory markers, such as:
   - Erythrocyte sedimentation rate (ESR).
   - C-reactive protein (CRP).

Imaging Criteria

1. X-rays: Imaging studies of the hip may reveal:
   - Joint effusion.
   - Erosions or changes in bone density.
   - Signs of inflammation in the surrounding soft tissues.

2. MRI or Ultrasound: These modalities can be used to assess soft tissue involvement and joint inflammation more sensitively than X-rays.

Diagnosis Summary

The diagnosis of Reiter's disease (ICD-10 code M02.35) is primarily clinical, supported by laboratory and imaging findings. A comprehensive evaluation that includes a detailed patient history, physical examination, and appropriate tests is essential for accurate diagnosis. The presence of arthritis following a documented infection, along with associated symptoms, is critical for establishing the diagnosis.

In conclusion, the criteria for diagnosing Reiter's disease affecting the hip involve a combination of clinical history, laboratory tests, and imaging studies, all of which help to confirm the presence of this condition and rule out other potential causes of arthritis.

Reiter's disease, also known as reactive arthritis, is a type of inflammatory arthritis that can occur following an infection, particularly in the urogenital or gastrointestinal tract. The ICD-10 code M02.35 specifically refers to Reiter's disease affecting the hip. Treatment approaches for this condition typically focus on alleviating symptoms, managing inflammation, and addressing any underlying infections. Below is a detailed overview of standard treatment strategies.

Standard Treatment Approaches

1. Medications

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

NSAIDs are often the first line of treatment for managing pain and inflammation associated with Reiter's disease. Commonly used NSAIDs include:
- Ibuprofen
- Naproxen
- Indomethacin

These medications help reduce swelling and discomfort, allowing patients to maintain mobility.

Corticosteroids

In cases where NSAIDs are insufficient, corticosteroids may be prescribed. These can be administered orally or injected directly into the affected joint to provide rapid relief from inflammation. Common corticosteroids include:
- Prednisone
- Methylprednisolone

Disease-Modifying Antirheumatic Drugs (DMARDs)

For chronic cases or when joint damage is a concern, DMARDs may be considered. These medications help slow disease progression and prevent joint damage. Examples include:
- Methotrexate
- Sulfasalazine

2. Physical Therapy

Physical therapy plays a crucial role in the rehabilitation of patients with Reiter's disease. A physical therapist can design a tailored exercise program to:
- Improve joint function
- Enhance flexibility
- Strengthen surrounding muscles

Therapeutic exercises can help maintain mobility and reduce stiffness in the hip joint.

3. Management of Underlying Infections

Since Reiter's disease is often triggered by infections, it is essential to identify and treat any underlying infections. This may involve:
- Antibiotics for bacterial infections
- Antiviral medications if a viral infection is present

Addressing the root cause can significantly improve symptoms and prevent recurrence.

4. Lifestyle Modifications

Patients are encouraged to adopt lifestyle changes that can help manage symptoms and improve overall health. Recommendations may include:
- Regular low-impact exercise to maintain joint function
- Weight management to reduce stress on the hip joint
- Adequate hydration and a balanced diet to support overall health

5. Surgical Interventions

In severe cases where joint damage is significant, surgical options may be considered. These can include:
- Arthroscopy to remove inflamed tissue or debris from the joint
- Joint replacement surgery if the hip joint is severely damaged

Conclusion

The management of Reiter's disease affecting the hip (ICD-10 code M02.35) involves a multifaceted approach that includes medication, physical therapy, and lifestyle modifications. Early intervention and a tailored treatment plan can significantly improve outcomes and enhance the quality of life for affected individuals. Regular follow-up with healthcare providers is essential to monitor the condition and adjust treatment as necessary. If you have further questions or need more specific information, consulting a healthcare professional is recommended.

Reiter's disease, also known as reactive arthritis, is a type of inflammatory arthritis that typically occurs in response to an infection in another part of the body. The ICD-10-CM code M02.35 specifically refers to Reiter's disease affecting the hip joint. Below is a detailed clinical description and relevant information regarding this condition.

Clinical Description of Reiter's Disease

Definition

Reiter's disease is characterized by a triad of symptoms: arthritis, urethritis, and conjunctivitis. It is often triggered by infections, particularly those caused by certain bacteria such as Chlamydia trachomatis, Salmonella, Shigella, or Yersinia. The condition primarily affects young adults and is more common in males than females.

Symptoms

The symptoms of Reiter's disease can vary but typically include:
- Joint Pain and Swelling: The hip joint may become inflamed, leading to pain, stiffness, and reduced range of motion. This can significantly impact mobility and daily activities.
- Urethritis: Patients may experience painful urination or discharge, indicating inflammation of the urethra.
- Conjunctivitis: Eye inflammation can occur, leading to redness, irritation, and discharge.
- Skin Manifestations: Some individuals may develop skin rashes or lesions, particularly on the soles of the feet or palms.

Diagnosis

Diagnosis of Reiter's disease involves a combination of clinical evaluation and laboratory tests. Key diagnostic steps include:
- Medical History: A thorough history to identify any recent infections or symptoms consistent with the disease triad.
- Physical Examination: Assessment of joint swelling, tenderness, and range of motion.
- Laboratory Tests: Blood tests may reveal elevated inflammatory markers, and tests for specific infections may be conducted to identify triggers.

Treatment

Management of Reiter's disease focuses on alleviating symptoms and addressing the underlying infection. Treatment options may include:
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): These are commonly prescribed to reduce pain and inflammation.
- Corticosteroids: In cases of severe inflammation, corticosteroids may be used to control symptoms.
- Antibiotics: If a bacterial infection is identified, appropriate antibiotics will be prescribed to treat the underlying cause.
- Physical Therapy: Rehabilitation exercises may help improve joint function and mobility.

ICD-10-CM Code M02.35 Details

Code Breakdown

• M02.35: This code specifically denotes Reiter's disease affecting the hip joint. It is part of the broader category of reactive arthritis codes in the ICD-10-CM classification system.

Related Codes

• M02.351: Reiter's disease, right hip.
• M02.352: Reiter's disease, left hip.
• M02.39: Other specified reactive arthropathies, which may be used when the specific joint involvement is not documented.

Importance of Accurate Coding

Accurate coding is crucial for effective treatment planning, insurance reimbursement, and epidemiological tracking. The specificity of the M02.35 code helps healthcare providers communicate the exact nature of the condition, facilitating appropriate management strategies.

Conclusion

Reiter's disease, particularly when affecting the hip, can lead to significant discomfort and functional impairment. Understanding the clinical features, diagnostic criteria, and treatment options is essential for effective management. The ICD-10-CM code M02.35 plays a vital role in the classification and treatment of this condition, ensuring that patients receive the appropriate care based on their specific symptoms and needs.